T-cell lymphoma products.
T J
TJ
Bell
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D004167:Diphtheria Toxin; D006801:Humans; D007376:Interleukin-2; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D011506:Proteins / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011506:Proteins; D011993:Recombinant Fusion Proteins; D013764:Tetrahydronaphthalenes; C078456:denileukin diftitox; D000077610:Bexarotene